{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T09:05:48Z","timestamp":1772874348981,"version":"3.50.1"},"reference-count":60,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9]]},"abstract":"<jats:p>Von Hippel-Lindau disease is a genetic condition due to mutation of the Von Hippel-Lindau gene, which leads to an increased risk in the development of hemangioblastomas of the brain and spinal cord. The pathophysiology of disease and its clinical manifestations, as they pertain to the general neurologist, are discussed. Therapeutic management of central nervous system hemangioblastomas ranging from neurosurgical resection, radiation therapy, and systemic therapies is reviewed.<\/jats:p>","DOI":"10.1097\/nrl.0000000000000085","type":"journal-article","created":{"date-parts":[[2016,8,25]],"date-time":"2016-08-25T15:52:23Z","timestamp":1472140343000},"page":"73-78","source":"Crossref","is-referenced-by-count":9,"title":["Neurological Management of Von Hippel-Lindau Disease"],"prefix":"10.1097","volume":"21","author":[{"given":"Trent S.","family":"Hodgson","sequence":"first","affiliation":[{"name":"Department of Neurology, Cornell University, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah M.","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Department of Medicine-Section of Hematology & Oncology, University of Chicago"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej S.","family":"Lesniak","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rimas V.","family":"Lukas","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Chicago, Chicago"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230929","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","article-title":"von Hippel-Lindau disease","volume":"361","author":"Lonser","year":"2003","journal-title":"Lancet"},{"key":"R2-20230929","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/ejhg.2010.175","article-title":"von Hippel-Lindau disease: a clinical and scientific review","volume":"19","author":"Maher","year":"2011","journal-title":"Eur J Hum Genet"},{"key":"R3-20230929","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/B978-0-444-62702-5.00010-X","article-title":"Von Hippel-Lindau disease","volume":"132","author":"Chittibonia","year":"2015","journal-title":"Handb Clin Neurol"},{"key":"R4-20230929","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.semcancer.2012.05.005","article-title":"Von Hippel-Lindau: how a rare disease illuminates cancer biology","volume":"23","author":"Richard","year":"2013","journal-title":"Semin Cancer Biol"},{"key":"R5-20230929","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1148\/rg.281075052","article-title":"Imaging features of von Hippel-Lindau disease","volume":"28","author":"Leung","year":"2008","journal-title":"Radiographics"},{"key":"R6-20230929","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1586\/ern.11.124","article-title":"Management of von Hippel-Lindau disease-associated CNS lesions","volume":"11","author":"Wind","year":"2011","journal-title":"Expert Rev Neurother"},{"key":"R7-20230929","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/jmg.28.7.443","article-title":"Von Hippel-Lindau disease: a genetic study","volume":"28","author":"Maher","year":"1991","journal-title":"J Med Gent"},{"key":"R8-20230929","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/0140-6736(91)91705-Y","article-title":"Clustering of features and genetics of von Hippel-Lindau disease: evidence for a complex genetic locus","volume":"337","author":"Neumann","year":"1991","journal-title":"Lancet"},{"key":"R9-20230929","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3171\/2014.1.JNS131431","article-title":"Prospective natural history study of central nervous system hemangioblastomas in von Hippel-Lindau disease","volume":"120","author":"Lonser","year":"2014","journal-title":"J Neurosurg"},{"key":"R10-20230929","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1136\/jmedgenet-2011-100562","article-title":"Life expectancy in hereditary cancer predisposing diseases: an observational study","volume":"49","author":"Wilding","year":"2012","journal-title":"J Med Genet"},{"key":"R11-20230929","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00432-014-1654-y","article-title":"Renal tumor size is an independent prognostic factor for overall survival in von Hippel-Lindau disease","volume":"140","author":"Kwon","year":"2014","journal-title":"J Cancer Res Clin Oncol"},{"key":"R12-20230929","doi-asserted-by":"crossref","first-page":"157","DOI":"10.5003\/2151-4194.2.1.157","article-title":"Management of central nervous system metastases from renal cancer","volume":"2","author":"Lukas","year":"2011","journal-title":"Emerg Cancer Ther"},{"key":"R13-20230929","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3171\/spi.2005.3.6.0495","article-title":"Spinal hemangioblastoma containing metastatic renal cell carcinoma in von Hippel-Lindau disease","volume":"3","author":"Altinoz","year":"2005","journal-title":"J Neurosurg Spine"},{"key":"R14-20230929","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1148\/radiology.202.3.9051037","article-title":"Papillary endolymphatic sac tumors: CT, MR imaging, and angiographic findings in 20 patients","volume":"202","author":"Mukherji","year":"1997","journal-title":"Radiology"},{"key":"R15-20230929","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1001\/jama.1997.03540420057030","article-title":"Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease","volume":"277","author":"Manski","year":"1997","journal-title":"JAMA"},{"key":"R16-20230929","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3109\/08820538.2013.825281","article-title":"Von Hippel-Lindau disease: a genetic and clinical review","volume":"28","author":"Haddad","year":"2013","journal-title":"Semin Ophthalmol"},{"key":"R17-20230929","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrc885","article-title":"Molecular basis of the VHL hereditary cancer syndrome","volume":"2","author":"Kaelin","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"R18-20230929","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/(SICI)1098-1004(1996)8:4<348::AID-HUMU8>3.0.CO;2-3","article-title":"Germline mutations in the von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan","volume":"8","author":"Zbar","year":"1996","journal-title":"Human Mutat"},{"key":"R19-20230929","first-page":"521","article-title":"Genetic analysis of von Hippel-Lindau disease","volume":"31","author":"Nordstrom-O\u2019Brien","year":"2010","journal-title":"Hum Mutat"},{"key":"R20-20230929","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/(SICI)1098-1004(1998)12:6<417::AID-HUMU8>3.0.CO;2-K","article-title":"Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene","volume":"12","author":"Stolle","year":"1998","journal-title":"Human Mutat"},{"key":"R21-20230929","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1093\/hmg\/4.11.2139","article-title":"Molecular analysis of de novo germline mutations in the von Hippel-Lindau disease gene","volume":"4","author":"Richards","year":"1995","journal-title":"Hum Mol Gent"},{"key":"R22-20230929","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/qjmed\/77.2.1151","article-title":"Clinical features and natural history of Von Hippel-Lindau disease","volume":"77","author":"Maher","year":"1990","journal-title":"Q J Med"},{"key":"R23-20230929","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/jnci\/djg024","article-title":"Pheochromocytoma: the expanding genetic differential diagnosis","volume":"95","author":"Bryant","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"R24-20230929","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/jmg.33.8.716","article-title":"Genotypephenotype correlation in von Hippel-Lindau disease: identification of a mutation associated with VHL type 2A","volume":"33","author":"Chen","year":"1996","journal-title":"J Med Genet"},{"key":"R25-20230929","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrclinonc.2010.42","article-title":"Alterations in VHL as potential biomarkers in renal-cell carcinoma","volume":"7","author":"Gossage","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"R26-20230929","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature12222","article-title":"Comprehensive molecular characterization of clear cell renal cell carcinoma","volume":"499","year":"2013","journal-title":"Nature"},{"key":"R27-20230929","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1200\/JCO.2004.05.061","article-title":"Role of VHL gene mutation in human cancer","volume":"22","author":"Kim","year":"2004","journal-title":"J Clin Oncol"},{"key":"R28-20230929","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S1097-2765(00)80096-9","article-title":"The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix","volume":"1","author":"Ohh","year":"1998","journal-title":"Mol Cell"},{"key":"R29-20230929","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1128\/MCB.26.7.2519-2530.2006","article-title":"pVHL function is essential for endothelial extracellular matrix deposition","volume":"26","author":"Tang","year":"2006","journal-title":"Mol Cell Biol"},{"key":"R30-20230929","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/ncb899","article-title":"Regulation of microtubule stability by the von Hippel-Lindau tumor suppressor protein pVHL","volume":"5","author":"Hergovich","year":"2003","journal-title":"Nat Cell Biol"},{"key":"R31-20230929","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.molcel.2006.04.006","article-title":"p53 stabilization and transactivation by a von Hippel-Lindau protein","volume":"22","author":"Roe","year":"2006","journal-title":"Mol Cell"},{"key":"R32-20230929","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nrc2502","article-title":"The von Hippel-Lindau tumor suppressor protein: O2 sensing and cancer","volume":"8","author":"Kaelin","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"R33-20230929","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/ng0594-85","article-title":"Mutations of the VHL tumour suppressor gene in renal carcinoma","volume":"7","author":"Gnarra","year":"1994","journal-title":"Nat Genet"},{"key":"R34-20230929","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.1158\/1078-0432.CCR-04-0516","article-title":"The in vitro and in vivo effects of re-expressing methylated von Hippel-Lindau tumor suppressor gene in clear cell renal carcinoma with 5-aza-2\u2019-deoxycytidine","volume":"10","author":"Alleman","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R35-20230929","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.otc.2014.12.006","article-title":"Endolymphatic sac tumors","volume":"48","author":"Wick","year":"2015","journal-title":"Otolaryngol Clin North Am"},{"key":"R36-20230929","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000362389","article-title":"Treatment of brain metastases","volume":"87","author":"Lukas","year":"2014","journal-title":"Oncology"},{"key":"R37-20230929","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3171\/JNS\/2008\/108\/2\/0210","article-title":"Surgical management of cerebellar hemangioblastomas in patients with von Hippel-Lindau disease","volume":"108","author":"Jagannathan","year":"2008","journal-title":"J Neurosurg"},{"key":"R38-20230929","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00701-012-1514-y","article-title":"Clinical features of patients bearing central nervous system hemangioblastoma in von Hippel-Lindau disease","volume":"155","author":"Kanno","year":"2013","journal-title":"Acta Neurochir (Wien)"},{"key":"R39-20230929","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jocn.2010.12.050","article-title":"A 10-year retrospective study of hemangioblastomas of the central nervous system with reference to von Hippel-Lindau (VHL) disease","volume":"18","author":"Padhi","year":"2011","journal-title":"J Clin Neurosci"},{"key":"R40-20230929","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3171\/jns.2003.98.1.0082","article-title":"The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease","volume":"98","author":"Wanebo","year":"2003","journal-title":"J Neurosurg"},{"key":"R41-20230929","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/jmg.33.2.120","article-title":"A genetic register for von Hippel Lindau disease","volume":"33","author":"Maddock","year":"1996","journal-title":"J Med Genet"},{"key":"R42-20230929","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3171\/2012.7.JNS12367","article-title":"Effect of pregnancy on hemangioblastoma development and progression in von Hippel-Lindau disease","volume":"117","author":"Ye","year":"2012","journal-title":"J Neurosurg"},{"key":"R43-20230929","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1212\/WNL.0b013e3182661f3c","article-title":"Pregnancy-related hemangioblastoma progression and complications in von Hippel-Lindau disease","volume":"79","author":"Frantzen","year":"2012","journal-title":"Neurology"},{"key":"R44-20230929","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.3171\/2012.11.JNS122145","article-title":"Pregnancy and von Hippel-Lindau disease","volume":"118","author":"Frantzen","year":"2013","journal-title":"J Neurosurg"},{"key":"R46-20230929","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.wneu.2014.05.024","article-title":"Sporadic spinal hemangioblastomas can be effectively treated by microsurgery alone","volume":"82","author":"Sun","year":"2014","journal-title":"World Neurosurg"},{"key":"R47-20230929","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/1097-0142(19820201)49:3<553::AID-CNCR2820490326>3.0.CO;2-A","article-title":"Cerebellar hemangioblastomas","volume":"49","author":"Sung","year":"1982","journal-title":"Cancer"},{"key":"R48-20230929","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1227\/NEU.0b013e31828ba793","article-title":"Hemangioblastomas and neurogenic polyglobulia","volume":"72","author":"Glasker","year":"2013","journal-title":"Neurosurgery"},{"key":"R49-20230929","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3171\/2012.7.GKS121019","article-title":"Same-day stereotactic aspiration and Gamma Knife surgery for cystic intracranial tumors","volume":"suppl","author":"Liu","year":"2012","journal-title":"J Neurosurg"},{"key":"R50-20230929","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0360-3016(96)80011-3","article-title":"Radiosurgery for hemangioblastoma: results of a multiinstitutional experience","volume":"35","author":"Patrice","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R51-20230929","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/neuonc\/not201","article-title":"The long-term outcomes of radiosurgery for intracranial hemangioblastomas","volume":"16","author":"Hanakita","year":"2014","journal-title":"Neuro Oncol"},{"key":"R52-20230929","first-page":"91","article-title":"Radiosurgery using Cyberknife for benign spinal tumors: Korea Cancer Center Hospital experience","volume":"101","author":"Chang","year":"2011","journal-title":"J Neurosurg"},{"key":"R53-20230929","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijrobp.2010.01.040","article-title":"Tolerance of the spinal cord to stereotactic radiosurgery: insights from hemangioblastomas","volume":"80","author":"Daly","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R54-20230929","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/neuonc\/nop018","article-title":"Prospective evaluation of radiosurgery for hemangioblastomas in von Hippel-Lindau disease","volume":"12","author":"Ashthigiri","year":"2010","journal-title":"Neuro Oncol"},{"key":"R55-20230929","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.critrevonc.2012.10.001","article-title":"Mechanisms, indications and results of salvage systemic therapy for sporadic and von Hippel-Lindau related hemangioblastomas of the central nervous system","volume":"86","author":"Capitano","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"key":"R56-20230929","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/pbc.22065","article-title":"Monotherapy with thalidomide for treatment of spinal cord hemangioblastomas in a patient with von Hippel-Lindau disease","volume":"53","author":"Sardi","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"R57-20230929","first-page":"510","article-title":"Interferon \u03b1-2a therapy in 18 hemangioblastomas","volume":"7","author":"Niemela","year":"2001","journal-title":"Clin Cancer Res"},{"key":"R58-20230929","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jama.291.8.943","article-title":"Antiangiogenic therapy for von Hippel-Lindau disease","volume":"291","author":"Madhusudan","year":"2004","journal-title":"JAMA"},{"key":"R59-20230929","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0002-9394(03)00101-6","article-title":"Treatment of von Hippel-Lindau retinal hemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than for hemangioblastomas","volume":"136","author":"Girmens","year":"2003","journal-title":"Am J Ophthalmol"},{"issue":"suppl 1","key":"R60-20230929","first-page":"32","article-title":"von Hippel-Lindau syndrome: target for anti-vascular endothelial growth factor (VEGF) therapy","volume":"5","author":"Harris","year":"2005","journal-title":"Oncologist"},{"key":"R61-20230929","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1093\/annonc\/mdr011","article-title":"Pilot trial of sunitinib therapy in patients with von Hippel-Lindau disease","volume":"22","author":"Jonasch","year":"2011","journal-title":"Ann Oncol"}],"container-title":["The Neurologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00127893-201609000-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T09:38:32Z","timestamp":1695980312000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00127893-201609000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/nrl.0000000000000085","relation":{},"ISSN":["1074-7931"],"issn-type":[{"value":"1074-7931","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}